Contrave weight loss pill gets FDA approval

It is hard to lose weight. With the approval of Contrave, overweight and obese receive a helping hand to improve weight loss, together with regular exercise and a healthy diet.
(Photo: Morten Amundsen)

Contrave gets green light from the Food and Drug Administration, the third weight loss pill to be approved in the United States in the last two years.

According to the FDA, Contrave was approved for use in the treatment of chronic weight together with regular exercise and a low calorie diet. Orexigen Therapeutics Inc. is the weight loss pill designed to control cravings and reduce appetite, the same functions as previously approved drugs and Qsymia Belviq offer.

About 79 million American adults are obese, according to the Centers for Disease Control and Prevention and the State in the amount of $ 147 billion in medical costs of 2008.

According to Jean-Marc Guettier, Division of Endocrinology and Metabolism Director of the FDA Center for Drug Evaluation and Research, Contrave offers another treatment option for the treatment of chronic weight for those who are overweight or obese and diagnosed with at least one health problem, such as high blood pressure or type 2 diabetes weight type.

Contraves is a combination of naltrexone and bupropion. Bupropion is an antidepressant during naltrexone prevents opiate dependence that the drug for the patient makes bearable.

The Contrave used should be evaluated after 12 weeks of use, in order to assess whether this weight loss treatment works online. If the patient does not lose at least 5 percent of their initial body weight, Contrave should be removed because it is no longer probable that more weight be lost if treatment is continued.

Adding to the list of weight loss pills on the market Contrave officially distributed is good news, because it expands the opportunities for people who are overweight and obese, but selling drugs weight loss is not as fast as expected. Given the number of people who could benefit with a weight loss pill, why not Belviq and Qsymia sales as they should?

One obstacle is the lack of long-term evidence that the pills work on achieving weight loss for the patient. People in need of treatment are also concerned about the use of weight loss pills, because despite its many advantages fear side effects bring her with him.

But even if a patient wants to weight loss pills are usually deterred by the cost to use, especially if the health insurance companies and the government does not treat lightly the costs incurred for the treatment of obesity. In fact, only 30 to 40 percent of the maintenance organizations health insurance for obesity. And all this is usually only a part of the bill, so that patients always pay in the end for most of the costs.

Contrave is also expected to enter the UK market in 2015.

© 2014 Tech-times, all rights reserved. Only with no approval.